Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06139770 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Anorexia Nervosa in Children and Adolescents: An Integrated Family Based and Metacognitive Approach

Study acronym: FBT-MCT
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoint(s) modified Show 8 more changesShow less
    • Trial completed
    • Final enrollment: 30 participants (planned 48)
    • Primary completion date changed from estimate of Dec 1, 2025 to May 1, 2026
    • Interventions modified
    • Trial arms changed: 2 → 1
    • Study completion date changed from estimate of Dec 1, 2026 to Aug 1, 2026
    • Eligibility criteria expanded, about 7 words
    • Study description shortened, about 2 words
  2. Minor Re-verified, no change to tracked fieldsv2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to evaluate the treatment effects of an integrated treatment called Family-based and Metacognitive therapy for patients with Anorexia Nervosa. In addition, we will evaluate if an active follow-up of the patients will reduce the number of relapses, which is common during the 1 year after discharge. Fifty patients aged 12-18 years old and their parents will be invited to participate in this study and all will receive the same treatment but be randomly allocated to different follow-up conditions. The active follow-up includes 3 sessions of Metacognitive therapy and the passive follow-up includes ordinary follow-up, with no booster sessions. The patients will be assessed at baseline, pre-treatment, post-treatment, and at 6 and 12 months follow-up.
Trial Details
NCT Number NCT06139770
Lead Sponsor Norwegian University of Science and Technology
Collaborators: St. Olavs Hospital
Conditions
(from sponsor)
Anorexia Nervosa
Related terms Anorexia Nervosa
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov